UV Infection Control Devices Market Key Companies CVS Health Corporation, DocMorris, Express Scripts Holding Company, Giant Eagle Inc., Optum Rx Inc., Rowlands Pharmacy

Global UV Infection Control Devices Industry garnered $317.42 million in 2018, and is expected to reach $524.84 million by 2026, growing at a CAGR of 6.5% from 2019 to 2026. The report provides a detailed analysis of changing market trends, major segments, current market size & projections, market share, and competitive scenario.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6472

Focus of governments on infection control programs, surge in prevalence of hospital acquired infections (HAI), and increase in adoption of technologically advanced UV equipment drive the growth of the global UV infection control devices market. However, high costs and strict government regulations hinder the market growth. On the other hand, untapped potential in emerging countries create new opportunities in coming years.

The report offers a detailed segmentation of the global UV infection control devices market on the basis of type, end user, and region. Based on type, the mobile segment held more than two-fifths of the total market share in 2018, and is expected to maintain its lead position throughout the forecast period. Moreover, this segment is expected to maintain its fastest CAGR of 7.3% from 2019 to 2026. The research also analyzes segments including stationary and others.

Based on end user, the hospitals segment contributed to the highest share of the total market, accounting for nearly half of the global market in 2018, and is estimated to maintain its dominant position in terms of revenue by 2026. Moreover, this segment is estimated to register the fastest CAGR of 6.8% during the forecast period. The report also discusses segments including clinics and others.

Based on region, North America held the highest market share in terms of revenue, contributing to more than two-fifths of the total market share in 2018, and is estimated to maintain its highest share throughout the forecast period. However, Asia-Pacific is expected to witness the highest CAGR of 8.1% from 2019 to 2026. The research also analyzes segments including Europe and LAMEA.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6472

Key players of the global UV infection control devices market analyzed in the research include CVS Health Corporation, Express Scripts Holding Company, DocMorris, Optum Rx Inc., Giant Eagle Inc., The Kroger Co., Rowlands Pharmacy, Walmart Stores Inc., Walgreen Co., and Apollo Pharmacy. They have adopted various strategies including collaborations, partnerships, mergers & acquisitions, new product launches, and others to gain a strong position in the industry.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.